Trade Mark 1307617 | IP Australia

Advanced search

Number: 1307617

Words: QUINTILES
Status: registered: Registered/protected
Priority date: 08 Jan 2009 (Convention)
Classes: 35, 36, 42, 44, 45
Kind: Word

QUINTILES

Goods & Services

Class 35:: Market research and analysis services in the fields of pharmaceuticals, pharmacogenomics and biotechnology; providing business information, namely, information useful for achieving and maintaining regulatory approval and market introduction of drugs, devices and biologics; business services in the pharmaceutical, biotechnology and life sciences fields, namely, providing business advice to clients and investors regarding the development and commercialization of products and business management of product portfolios and providing business advice to clients and investors in managing commercial alliance relationships

Class 36:: Providing financial services in the pharmaceutical, biotechnology and life sciences fields, namely, providing financing to pharmaceutical, biotechnology and life sciences companies for product development and commercialization, making acquisitions of products and product rights of and investments in pharmaceutical, biotechnology and life sciences companies; capital funding services to pharmaceutical, biotechnology and life sciences companies for the development and commercialization of new products, management of product portfolios, prioritization of financial resources and achievement of financial objectives; and providing financial consultation in connection with all of the above

Class 42:: Clinical research and testing services in the fields of pharmacogenomics and medical devices; product development consultation in the fields of medical products and devices; healthcare policy research and development services; laboratory testing services in the fields of pharmaceutical, pharmacogenomic, biotechnical and medical products and devices; consultancy pertaining to pharmacology and biotechnical research; managing, monitoring and coordinating clinical studies on human subjects for others; consultation services in the field of compliance evaluation to insure validity and accuracy of regulatory submissions to the FDA by life sciences companies; conducting regulatory and compliance audits for others in the fields of pharmaceutical, pharmacogenomic, biotechnical and medical products and devices

Class 44:: Providing health, medical, pharmaceutical, health management and disease management information to others; medical evaluation services, namely, developing and implementing disease management and treatment protocols and patient outcome analysis services; consulting services in the fields of health care, medical and pharmaceuticals

Class 45:: Regulatory research in the pharmaceutical industry, biotechnology industry and the medical and diagnostics industry; consulting services in the fields of regulatory affairs, manufacturing compliance and validation; providing regulatory information and implementation services relating to the development and validation of drugs, devices and biologics

Convention details

Date:

08 Jan 2009

Number:

098000437

Country:

TAIWAN

Opposition details

No oppositions information available.

History and Publications

Date	Description
29 May 2019	IP Right Renewed correspondence sent
29 May 2019	Renewal Requested
01 May 2019	Renewal Reminder correspondence sent
30 Aug 2018	Full Assignment - Subsequent Owner Registered Published
17 Aug 2018	Full Assignment	More
	Event description TM NUMBER 1318325 IS THE HEAD CASE Previous details Data as before the amendment: Amend No 19 Occurence 1 <ADDRESS FORSERVICE/CLASSES> <CLASSES> 35,36,42,44,45 Occurence 2 <ASSIGNED FROM> <NAME ID> 745330 <NAME PREFIX> C <REMAINDER> Quintiles Transnational Corp. 4820 Emperor Boulevard, Durham, North Carolina, 27703 Occurence 3 <REPEATED FROM> <HEAD CASE> 1318325 <AMEND NO> 20 Occurence 4 <ASSIGNED TO> <NAME ID> 37560 <NAME PREFIX> C <REMAINDER> IQVIA Inc. 100 IMS Drive Parsippany NJ 07054 Occurence 5 <3RD-PARTY-NOTICE-ADDRESS> Dennemeyer & Associates Level 2 35 Cotham Rd KEW VIC 3101 Occurence 6 <ASSIGNMENT> By Copy of Certificate of Merger Dated 03 October 2016 New details
10 Aug 2018	Application for Assignment
02 Jul 2018	Registration Status Change
25 Jan 2011	Amend Name/Address	More
	Event description TM NUMBER 639977 IS THE HEAD CASE Previous details Amendment : Amend No 17 Occurrence 1 <REPEATED FROM> <TM NO> 639977 <AMEND NO> 17 <NAME ID> 977886 Occurrence 2 <AMEND ADDRESS> <NAME ID> 977886 <NAME> Quintiles Transnational Corp. <ADDRESS> 4709 Creekstone Drive, Suite 200, Durham, North Carolina, 27703, 0 UNITED STATES OF AMERICA New details
20 Jan 2011	Amend Trade Mark Registration Particulars
24 Dec 2009	IP Right Registration Published
07 Dec 2009	Application Status
07 Dec 2009	Register Trade Mark
27 Nov 2009	Registration fee (5 classes)
27 Aug 2009	IP Right Acceptance Published
10 Aug 2009	Application Accepted correspondence sent
10 Aug 2009	Clear Examination report approved
07 Aug 2009	Goods and Services Classes	More
	Event description Applicant's Request Previous details Data as before the amendment: Amend No 8 Occurence 1 3500936010420114401245013 $ $ $ <BCLASS>3536424445 $ New details
07 Aug 2009	Goods and Services description amendment	More
	Event description Applicant's Request Previous details Data as before the amendment: Amend No 12 Occurence 1 Providing health, medical, pharmaceutical, health management and disease management information to others; medical evaluation services, namely, developing and implementing disease management and treatment protocols and patient outcome analysis services; consulting services in the fields of health care, medical and pharmaceuticals New details
07 Aug 2009	Goods and Services description amendment	More
	Event description Applicant's Request Previous details Data as before the amendment: Amend No 11 Occurence 1 Clinical research and testing services in the fields of pharmacogenomics and medical devices; product development consultation in the fields of medical products and devices; healthcare policy research and development services; laboratory testing services in the fields of pharmaceutical, pharmacogenomic, biotechnical and medical products and devices; consultancy pertaining to pharmacology and biotechnical research; managing, monitoring and coordinating clinical studies on human subjects for others New details
07 Aug 2009	Goods and Services description amendment	More
	Event description Applicant's Request Previous details Data as before the amendment: Amend No 10 Occurence 1 Providing financial services in the pharmaceutical, biotechnology and life sciences fields, namely, providing financing to pharmaceutical, biotechnology and life sciences companies for product development and commercialization, making acquisitions of products and product rights of and investments in pharmaceutical, biotechnology and life sciences companies; capital funding services to pharmaceutical, biotechnology and life sciences companies for the development and commercialization of new products, management of product portfolios, prioritization of financial resources and achievement of financial objectives; and providing financial consultation in connection with all of the above New details
07 Aug 2009	Goods and Services description amendment	More
	Event description Applicant's Request Previous details Data as before the amendment: Amend No 9 Occurence 1 Market research and analysis services in the fields of pharmaceuticals, pharmacogenomics and biotechnology; providing business information, namely, information useful for achieving and maintaining regulatory approval and market introduction of drugs, devices and biologics; business services in the pharmaceutical, biotechnology and life sciences fields, namely, providing business advice to clients and investors regarding the development and commercialization of products and business management of product portfolios and providing business advice to clients and investors in managing commercial alliance relationships New details
07 Aug 2009	Goods and Services description amendment	More
	Event description Applicant's Request Previous details Data as before the amendment: Amend No 13 Occurence 1 Regulatory research in the pharmaceutical industry, biotechnology industry and the medical and diagnostics industry; consultation services in the field of compliance evaluation to insure validity and accuracy of regulatory submissions to the FDA by life sciences companies; conducting regulatory and compliance audits for others in the fields of pharmaceutical, pharmacogenomic, biotechnical and medical products and devices; consulting services in the fields of regulatory affairs, manufacturing compliance and validation; providing regulatory information and implementation services relating to the development and validation of drugs, devices and biologics New details
05 Aug 2009	Exam Response
27 Jul 2009	Adverse Report correspondence sent
27 Jul 2009	Application Status
23 Jul 2009	IP Right Filed Published
13 Jul 2009	Application Status
07 Jul 2009	Application Status
07 Jul 2009	Application Status
07 Jul 2009	Status change to Filed
01 Jul 2009	New Trademark Application

Dates

Renewal due: 01 Jul 2029
Registration advertised / published: 24 Dec 2009
Entered on Register: 07 Dec 2009
Acceptance advertised / published: 27 Aug 2009
Acceptance: 10 Aug 2009
Filing: 01 Jul 2009
Registered from: 01 Jul 2009

Owner

Address for service

Indexing constituents

Word

QUINTILES

Image

Australian Trade Mark Search

Goods & Services

Convention details

Opposition details

History and Publications

Dates

Owner

Address for service

Indexing constituents